Characterization of the genomic landscape and actionable mutations in Chinese breast cancers by clinical sequencing
Chinese breast cancer patients have not been well represented in clinical sequencing studies. Here the authors analyse the mutational landscape of 1,134 Chinese breast cancer patients, finding actionable targets and a higher prevalence of p53 and Hippo pathway mutations compared to Western cohorts.
Enregistré dans:
Auteurs principaux: | , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2020
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/61dd0a122435489e99726b2dc7d128dc |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|